Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary presents a balanced view. Financial performance and product development are strong, with positive mortality variances and high new business strain. Market strategy and shareholder return plans are optimistic, with investments in growth and a focus on IFRS. The Q&A reveals some uncertainties, such as unclear management responses and legal settlements, but overall sentiment remains positive due to strong operational metrics and optimistic guidance.
Operating capital generation before holding and funding expenses EUR 1.3 billion, increased year-over-year. Reasons: Business growth across all units, stable market impacts, and improved experience variances in the Americas and international businesses.
Operating results EUR 1.7 billion, increased by 15% compared with 2024. Reasons: Business growth across all units, stable market impacts, and improved experience variances in the Americas and international businesses.
Free cash flow EUR 829 million, consistent with the target. Reasons: Strong capital position and financial performance.
Final dividend per common share EUR 0.21, resulting in a full year 2025 dividend of EUR 0.40 per share, up 14% from EUR 0.35 per share over 2024. Reasons: Strong financial performance.
Share buybacks EUR 400 million executed in the second half of 2025. Reasons: Capital return to shareholders.
New life sales Increased by 10% compared with 2024. Reasons: Higher agent productivity, higher average premium per policy, and growth in specific products like final expense and RILA sales.
Indexed annuity net deposits Increased by 45% in 2025. Reasons: Higher gross deposits and improved wholesale distribution productivity.
Net inflows in midsized retirement plans business Positive in 2025. Reasons: Strong positioning in the pool plan space and a large takeover deposit earlier in the year.
Operating results (second half 2025) EUR 858 million, increased by 11% year-on-year. Reasons: Business growth and favorable variances across all units.
Cash capital at holding EUR 1.3 billion at the end of 2025, decreased. Reasons: Capital distributions to shareholders in the form of dividend payments and share buybacks.
Gross financial leverage Stable at EUR 4.9 billion. Reasons: No significant changes in financial structure.
Group solvency ratio 184%, robust. Reasons: Strong capital position and financial management.
U.S. RBC ratio 424%, increased by 4 percentage points compared to June 2025. Reasons: Operating capital generation and remittances to the holding.
Valuation equity per share EUR 9.06 per share, increased by 7 percentage points over the second half of 2025. Reasons: Positive contributions from shareholders' equity and the CSM balance after tax.
OCG before holding, funding, and operating expenses Increased by 8% compared with the second half of 2024. Reasons: Favorable mortality and morbidity claims experience, favorable release of required capital, and reduction in short-term financing.
New life sales: Increased by 10% compared with 2024, driven by higher productivity and higher average premiums per policy sold.
Annuities sales: Increased by 6% due to productivity improvements in wholesale distribution.
Indexed annuity net deposits: Achieved a 45% increase in 2025.
Final expense product: Strong new life sales through a fully digital underwriting platform.
U.S. strategic assets: Continued growth in WFG, new life sales, and retirement plan assets.
Brazil joint venture: Higher new life sales, particularly in credit life products.
Spain and Portugal: Reported growth in new life sales.
China: New life sales negatively impacted by changes to product pricing and economic environment.
Operating capital generation: Increased year-over-year to EUR 1.3 billion, ahead of target.
Operating results: Increased by 15% compared with 2024 to EUR 1.7 billion.
Free cash flow: Achieved EUR 829 million for 2025, consistent with target.
Dividend per share: Proposed a final dividend of EUR 0.21 per share, resulting in a full-year dividend of EUR 0.40 per share, up 14% from 2024.
Relocation to the U.S.: Preparations for relocation progressing as planned, including U.S. GAAP implementation.
Capital employed in financial assets: Reduced to $2.7 billion, ahead of target.
Share buybacks: Executed EUR 400 million in 2025 and launched a new EUR 400 million program for 2026.
China new life sales: Negatively impacted by changes to product pricing to reflect the new pricing regulations and the current economic environment.
Aegon U.K. Adviser Platform business: Net outflows in 2025 reflected ongoing consolidation and vertical integration in nontarget adviser segments.
SGUL reinsurance transaction: Realized losses on assets transferred in the context of the transaction, which were unfavorable in the period.
Net impairments: Reflect an ECL reserve increase from new investment purchases as well as a small number of downgrades and defaults of bond investments.
Fair value items: Negative mostly from revaluations of solvency hedges in the U.K.
U.S. RBC ratio: Negatively impacted by onetime items and management actions during the period.
Revenue Growth: The company aims to grow the operating result of the group by around 5% per year over the 2026 to 2027 period, from the EUR 1.5 billion to EUR 1.7 billion run rate in 2025, assuming an exchange rate of $1.20 per euro.
Agent Expansion: The company plans to grow the number of licensed agents in the Americas to around 110,000 by 2027, up from nearly 96,000 at the end of 2025.
Productivity Improvements: Initiatives to improve agent productivity are expected to continue driving higher policy sales and premiums per policy.
Indexed Annuity Growth: The company achieved a 45% increase in indexed annuity net deposits in 2025 and aims to sustain growth through improved wholesale distribution productivity.
Retirement Plans Business: The midsized retirement plans business is expected to maintain solid written sales and net inflows, supporting gross deposits going forward.
Workplace Platform Growth: Aegon U.K. expects continued growth in net deposits driven by onboarding new schemes and members, as well as regular contributions from existing schemes.
Asset Management Expansion: The company plans to grow its higher revenue margin third-party business by expanding CLO warehouse capacity in the U.S. and Europe.
Capital Allocation: The company aims to reach the midpoint of the operating range for cash capital at holding around EUR 1.0 billion by the end of 2026.
Share Buyback Program: A share buyback program for 2026 totaling EUR 400 million has been announced, with the first half of EUR 227 million expected to be completed by June 30, 2026.
Proposed Final Dividend: EUR 0.21 per common share, resulting in a full year 2025 dividend of EUR 0.40 per share, up 14% from EUR 0.35 per share over 2024.
Share Buybacks: Executed EUR 400 million of share buybacks in the second half of 2025. Currently executing the first half of a new EUR 400 million buyback program for 2026.
The earnings call summary presents a balanced view. Financial performance and product development are strong, with positive mortality variances and high new business strain. Market strategy and shareholder return plans are optimistic, with investments in growth and a focus on IFRS. The Q&A reveals some uncertainties, such as unclear management responses and legal settlements, but overall sentiment remains positive due to strong operational metrics and optimistic guidance.
The earnings call reflects a solid financial performance with increased free cash flow and interim dividends, despite some negative aspects like decreased valuation equity per share. The company announced a share buyback program, which is typically seen positively. The Q&A did not reveal significant concerns, and management's confidence in achieving targets further supports a positive outlook. The market cap is not available, but the overall sentiment leans towards a positive reaction, likely resulting in a stock price increase of 2% to 8%.
The financial performance shows some positive aspects, such as increased operating capital generation and a healthy cash capital position. However, significant concerns include net outflows in retirement plans, market volatility impacting financial stability, and regulatory transition risks. The Q&A session highlighted uncertainty in capital return policies and unclear responses on mortality trends and hedging costs. The planned share buyback is positive but overshadowed by broader financial and strategic concerns, leading to a negative sentiment.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.